Berndt A. E. Modig
Fundador en PHARVARIS N.V. .
Fortuna: 34 M $ al 30/04/2024
Cargos activos de Berndt A. E. Modig
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PHARVARIS N.V. | Director/Miembro de la Junta | 30/09/2015 | - |
Director Ejecutivo | 30/09/2015 | - | |
Fundador | 30/09/2015 | - | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Director/Miembro de la Junta | - | - |
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Director/Miembro de la Junta | 04/05/2018 | - |
OncoBiotek SA
OncoBiotek SA BiotechnologyHealth Technology OncoBiotek SA engages in the provision of biotechnology research and development. The company was founded on January 1, 2009 and is headquartered in Châteauneuf-Villevieille, France. | Director/Miembro de la Junta | - | - |
Schoodic Management BV | Director Ejecutivo | - | - |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Director/Miembro de la Junta | 01/10/2015 | - |
Director Ejecutivo | 01/10/2015 | - | |
Fundador | 01/10/2015 | - |
Historial de carrera de Berndt A. E. Modig
Antiguos cargos conocidos de Berndt A. E. Modig.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CENTOGENE N.V. | Director/Miembro de la Junta | 01/04/2018 | 15/08/2023 |
Independent Dir/Board Member | 01/04/2018 | 15/08/2023 | |
SIO GENE THERAPIES INC. | Director/Miembro de la Junta | 01/03/2015 | 05/04/2023 |
Independent Dir/Board Member | 01/03/2015 | 05/04/2023 | |
KIADIS PHARMA N.V. | Director/Miembro de la Junta | 01/01/2016 | 01/04/2021 |
Independent Dir/Board Member | 01/01/2016 | 01/04/2021 | |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formación de Berndt A. E. Modig.
INSEAD | Masters Business Admin |
University of Lund | Undergraduate Degree |
Estadísticas
Internacional
Alemania | 7 |
Estados Unidos | 5 |
Países Bajos | 5 |
Operativa
Director/Board Member | 14 |
Independent Dir/Board Member | 5 |
Director of Finance/CFO | 4 |
Sectorial
Health Technology | 13 |
Commercial Services | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
AFFIMED N.V. | Health Technology |
PHARVARIS N.V. | Health Technology |
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
CENTOGENE N.V. | Commercial Services |
Empresas privadas | 17 |
---|---|
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
Surplex AG
Surplex AG Internet Software/ServicesTechnology Services Surplex AG operates an online business-to-business exchange for surplus assets and excess inventory. The private company is based in Dusseldorf, Germany. | Technology Services |
Pricewaterhouse LLP | Commercial Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Health Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
Schoodic Management BV | |
Hayward Industrial Products, Inc.
Hayward Industrial Products, Inc. Industrial MachineryProducer Manufacturing Hayward Industrial Products, Inc. supplies swimming pool equipment, industrial valves, strainers, and fittings. The company is headquartered in Elizabeth, NJ. | Producer Manufacturing |
Agra Industria | |
Mobile Loyalty Plc
Mobile Loyalty Plc Advertising/Marketing ServicesCommercial Services Mobile Loyalty Plc operates as a holding company with interests in mobile advertising services. The company was founded by Sterner de la Mau in 2007 and is headquartered in Malmo, Sweden. | Commercial Services |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
OncoBiotek SA
OncoBiotek SA BiotechnologyHealth Technology OncoBiotek SA engages in the provision of biotechnology research and development. The company was founded on January 1, 2009 and is headquartered in Châteauneuf-Villevieille, France. | Health Technology |
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Health Services |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Berndt A. E. Modig
- Experiencia